News for Eisai Co., Ltd. (EII.F)

SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new...

Press Release ???? ?-Current testing follows preceding pre-clinical tests indicating efficacy of the novel PARP inhibitor stenoparib against SARS-Cov-2, the virus... | February 24, 2021

Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The

Merck & Co Inc (NYSE: MRK) and Eisai Co Ltd (OCTMKT: ESALY) unveiled new data from the Phase 3 CLEAR ...

Eisai Co. Ltd.

BIOGEN REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Revenue: Fourth quarter $2,853 million; Full Year $13,445 million GAAP diluted EPS:... | February 3, 2021

The drug candidate will undergo an additional three months of review after a panel of experts in November voted that the clinical data didn’t show the drug to be effective.

Biogen Inc (NASDAQ: BIIB) shares are up sharply Friday after the company announced a delay in the FDA decision for its Alzheimer's treatment candidate, ...

According to Coherent Market Insights, the global epileptic seizures treatment market is estimated to be valued at US$ 3.0 billion in 2020 and is expected to exhibit a CAGR of 5.4% during the...

TORONTO, Jan. 25, 2021 /CNW/ - Corporate Knights 17th annual ranking of the world's 100 most sustainable corporations is being released this morni...

TORONTO, Jan. 25, 2021 /CNW/ - Corporate Knights 17th annual ranking of the world's 100 most sustainable corporations is being released this morni...